There are increasing calls for newborn babies across the UK to be routinely screened for Hereditary Fructose Intolerance (HFI), a rare genetic disorder that can have devastating consequences if left undiagnosed. The condition prevents the body from properly metabolising fructose, a sugar naturally present in many fruits, vegetables, and commonly added to processed foods and drinks. Early detection through universal screening, similar to existing heel prick tests for other conditions, could significantly improve the health outcomes for affected children.
HFI is inherited when a child receives a faulty gene from both parents. Individuals with HFI lack a functional aldolase B enzyme, which is crucial for breaking down fructose in the liver. When fructose accumulates in the body, it becomes toxic, leading to a range of severe symptoms including vomiting, nausea, abdominal pain, jaundice, liver enlargement, and kidney failure. In severe cases, particularly if the condition remains unmanaged, it can result in growth failure, seizures, coma, and even prove fatal.
Currently, diagnosis often only occurs once symptoms manifest, typically when infants are weaned onto solid foods containing fructose, such as fruit purees or vegetable mashes. This delay means that affected children may already have suffered significant damage to their internal organs by the time HFI is identified. Families often face a prolonged and distressing diagnostic journey, with multiple hospital visits and tests before the underlying cause is pinpointed.
Proponents of routine screening argue that the benefits of early detection far outweigh the costs. If HFI is identified at birth, dietary interventions can be implemented immediately, preventing the accumulation of toxic fructose and averting severe organ damage. This involves strict avoidance of all fructose-containing foods, a challenging but life-saving dietary regime. Such proactive management can ensure children with HFI lead healthier lives, avoiding the chronic health problems associated with late diagnosis.
The push for routine screening aligns with the principles of preventative healthcare, aiming to identify and manage conditions before they cause irreversible harm. While HFI is rare, affecting an estimated 1 in 20,000 to 1 in 30,000 people, its severe impact on those affected underscores the importance of early intervention. Implementing a screening programme would require careful consideration of logistics, cost-effectiveness, and public health policy, but advocates believe the long-term health benefits for children and the reduction in healthcare burden make a compelling case.
Organisations and families affected by HFI are spearheading the campaign, highlighting the daily challenges of managing the condition and the emotional toll of delayed diagnosis. They are urging health authorities to review current screening protocols and consider adding HFI to the standard panel of conditions tested at birth, offering a lifeline to future generations of children born with this often-misunderstood disorder.
Source: Hereditary Fructose Intolerance Network